Flibanserin's 'Effects' Do Not Outweigh Harms, Review Finds

Researchers review the existing trials for flibanserin (Addyi), or "female Viagra," and the very modest benefits of the drug do not outweigh the harms.

Related Keywords

United States ,Netherlands ,America ,Elisa Schwartz ,Steven Woloshin ,Erasmus University ,Drug Administration ,Sprout Pharmaceuticals ,National Women Health Network ,Drug Administration Approval Of Flibanserin ,Valeant Pharmaceuticals ,National Women ,Health Network ,Pink Pill ,Big Pharma ,Hypoactive Sexual Desire Disorder ,Systematic Review ,Drug Administration Approval ,Score Does Not Add ,Ass On The Pink Pill Or Pass Out ,Addyi ,Ven The Score ,Fda Advisory Committee ,Female Viagra ,Libanserin Addyi ,Hypoactive Sexual Desire Disorder Hsdd ,Ow Female Sexual Desire ,Ink Viagra ,Relationship Counselling ,Sex Therapist ,Sex Therapy ,